BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21170262)

  • 1. RalBP1 is necessary for metastasis of human cancer cell lines.
    Wu Z; Owens C; Chandra N; Popovic K; Conaway M; Theodorescu D
    Neoplasia; 2010 Dec; 12(12):1003-12. PubMed ID: 21170262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling.
    Tazat K; Harsat M; Goldshmid-Shagal A; Ehrlich M; Henis YI
    Mol Biol Cell; 2013 Jun; 24(11):1812-24. PubMed ID: 23576547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
    Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RALA and RALBP1 regulate mitochondrial fission at mitosis.
    Kashatus DF; Lim KH; Brady DC; Pershing NL; Cox AD; Counter CM
    Nat Cell Biol; 2011 Aug; 13(9):1108-15. PubMed ID: 21822277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of RalB is important for bladder cancer cell growth and metastasis.
    Wang H; Owens C; Chandra N; Conaway MR; Brautigan DL; Theodorescu D
    Cancer Res; 2010 Nov; 70(21):8760-9. PubMed ID: 20940393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
    Lim KH; Baines AT; Fiordalisi JJ; Shipitsin M; Feig LA; Cox AD; Der CJ; Counter CM
    Cancer Cell; 2005 Jun; 7(6):533-45. PubMed ID: 15950903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA.
    Lim KH; Brady DC; Kashatus DF; Ancrile BB; Der CJ; Cox AD; Counter CM
    Mol Cell Biol; 2010 Jan; 30(2):508-23. PubMed ID: 19901077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sec5 and Exo84 foster oncogenic ras-mediated tumorigenesis.
    Issaq SH; Lim KH; Counter CM
    Mol Cancer Res; 2010 Feb; 8(2):223-31. PubMed ID: 20145037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector.
    Neel NF; Rossman KL; Martin TD; Hayes TK; Yeh JJ; Der CJ
    Mol Cell Biol; 2012 Apr; 32(8):1374-86. PubMed ID: 22331470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cargo exocytosis by a Reps1-Ralbp1-RalA module.
    Wang S; Chen X; Crisman L; Dou X; Winborn CS; Wan C; Puscher H; Yin Q; Kennedy MJ; Shen J
    Sci Adv; 2023 Feb; 9(8):eade2540. PubMed ID: 36812304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sec5 and Exo84 mediate distinct aspects of RalA-dependent cell polarization.
    Hazelett CC; Yeaman C
    PLoS One; 2012; 7(6):e39602. PubMed ID: 22761837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ral GTPases in tumorigenesis: emerging from the shadows.
    Kashatus DF
    Exp Cell Res; 2013 Sep; 319(15):2337-42. PubMed ID: 23830877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RalA and RalB: antagonistic relatives in cancer cell migration.
    Oxford G; Owens CR; Titus BJ; Foreman TL; Herlevsen MC; Smith SC; Theodorescu D
    Cancer Res; 2005 Aug; 65(16):7111-20. PubMed ID: 16103060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.
    Smith SC; Baras AS; Owens CR; Dancik G; Theodorescu D
    Cancer Res; 2012 Jul; 72(14):3480-91. PubMed ID: 22586063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
    Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
    Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of KRAS and RAL in non-small-cell lung cancer growth and progression.
    Guin S; Ru Y; Wynes MW; Mishra R; Lu X; Owens C; Barn AE; Vasu VT; Hirsch FR; Kern JA; Theodorescu D
    J Thorac Oncol; 2013 Dec; 8(12):1492-501. PubMed ID: 24389431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
    Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
    Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.
    Oxford G; Smith SC; Hampton G; Theodorescu D
    Oncogene; 2007 Nov; 26(50):7143-52. PubMed ID: 17496927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ral-regulated interaction between Sec5 and paxillin targets Exocyst to focal complexes during cell migration.
    Spiczka KS; Yeaman C
    J Cell Sci; 2008 Sep; 121(Pt 17):2880-91. PubMed ID: 18697830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RalA activation at nascent lamellipodia of epidermal growth factor-stimulated Cos7 cells and migrating Madin-Darby canine kidney cells.
    Takaya A; Ohba Y; Kurokawa K; Matsuda M
    Mol Biol Cell; 2004 Jun; 15(6):2549-57. PubMed ID: 15034142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.